Asia Pacific Intrauterine devices (IUD’S) Market Share, Size, Trends and Forecast 2021

The Asia Pacific Intrauterine devices (IUD’S) Market was worth $ 364 million in 2016 and estimated to reach $ 456 million by the end of 2021 with a growing potential of 4.60 %. Asia-Pacific accounts to hold the largest share in the market.

Intrauterine devices (IUDs) are contraceptive medical implants used to avoid pregnancies for a long-time period. It is injected into the uterus, and their primary aim is to inhibit the fertilization of the egg by causing changes, such as toxicity or thickening of the cervical mucus, thus inhibiting fertilization by a sperm. Mirena, Skyla and Paragard are some of the prominent brands available in the market. In Asia-Pacific region, most of the people are adopting to modern contraception such as oral pill, injectable contraceptives, condoms, implants, IUDs and male or female sterilisation. Modern contraceptive methods are more effective than traditional methods. For example, the rate of sterilisation fails less than 1 per cent for modern contraception’s in comparison to 25 per cent for periodic abstinence.

Full report at: http://www.marketdataforecast.com/market-reports/asia-pacific-intrauterine-devices-market-1095/

Asia Pacific Intrauterine Device market is mainly driven by the factors such as Advancement in technical innovations, increasing prevalence of STD’S (Sexually transmitted diseases), instant health benefits other than birth control, increasing government initiatives to prevent unwanted abortions and pregnancies. The factors that are hindering the growth of the market are issues of Infertility, Religious and cultural opposition, Economic constraints, ectopic pregnancy, pelvic inflammatory infection, and Limited access to contraception.

The Asia Pacific Intrauterine Devices market is broadly categorized based on product type into Hormonal intrauterine device and Copper intrauterine device. The largest share in the market is held by Hormonal IUD’S. Since, they have less risks compared to non-hormonal IUD’S.

Request sample: http://www.marketdataforecast.com/market-reports/asia-pacific-intrauterine-devices-market-1095/request-sample

Key players influencing the Asia Pacific Intrauterine devices market are Agile Therapeutics, Actavis PLC, ANI Pharmaceuticals, Inc, Bayer AG, Teva Pharmaceutical, Pfizer, Mylan laboratories, Besins HealthCare, Brecuro Medical, Effik International, Eurogine, HLL Lifecare, HRA Pharma, Lupin Pharmaceuticals, Ltd, Okamato Industries, Inc.

About Market Data Forecast:
The publisher of this report is Market Data Forecast whose forte lies in Market research and Business Intelligence. Handling both individual and corporate clients across multiple business domains they offer syndicated/customized research to suit the client’s research objective. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering North America among other regions of the global market as well. For more info kindly visit, www.marketdataforecast.com

Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases

This release was published on openPR.